Drug Manufacturers—General Industry | Healthcare Sector | - CEO | XSHE Exchange | CNE000000Y11 ISIN |
China Country | 572 Employees | - Last Dividend | 23 Jun 2016 Last Split | - IPO Date |
Hunan Jingfeng Pharmaceutical Co., Ltd., established in 2003 and based in Shanghai, China, is engaged in the manufacturing and sale of chemical drugs and biological agents across the country. The company has carved out a niche in the pharmaceutical industry through its focus on sodium hyaluronate injection, primarily used in orthopedics and surgery applications. Expanding its portfolio, Hunan Jingfeng Pharmaceutical also invests in the research and development of novel therapeutics targeting major health concerns such as tumors, cancer, and cardiovascular diseases. In addition to its product offerings, the company extends its expertise by providing comprehensive Contract Development and Manufacturing Organization (CDMO) and Contract Manufacturing Organization (CMO) services, leveraging its advanced technological capabilities and industry experience.